2m 2m 2m 2m 2m 2m 2m
IMMUNOVANT (IMVT)
NASDAQ
$29.44+$1.05 (+3.72%)
Price as of Oct 22, 2026 7:30 PM EDT- $5.9BMarket Cap
- 50.16%1-Year Change
- BiotechnologyIndustry
IMMUNOVANT (IMVT)
$29.44+$1.05 (+3.72%)
Earnings Score
Valuation | IMVT | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | IMVT | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -5.67% | ||
12-Month Momentum | 93.92% | ||
3-Month Risk Adjusted Momentum | -42.98% | ||
12-Month Risk Adjusted Momentum | 164.13% |
True Yield
Valuation | IMVT | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | IMVT | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -1 |